Concerns HPV testing could miss rare cancers

The revamped cervical screening program does not include some increasingly prevalent HPV subtypes

Gynaecologists have flagged concerns that the switch to HPV DNA-based cervical screening means some rare cases of cancer or pre-cancerous lesions could be missed.